Fund shareholders of ImmuneOnco Biopharmaceuticals Shanghai
ISIN CNE100006624 · China · LEI 25490040OVM0N5Z3GG60
- Fund shareholders
- 3
- Of which ETFs
- 3 0 other funds
- Value held
- 463.5K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 735,600 | 363K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 168,200 | 83K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 35,400 | 17.5K $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 3 | -2 | 939,200 | -4.4 % |
| 2026Q2 | 5 | +2 | 982,800 | +3.6 % |
| 2026Q1 | 3 | 0 | 948,200 | +5.7 % |
| 2025Q4 | 3 | 897,400 |
Cite this page
Titelia. "Fund shareholders of ImmuneOnco Biopharmaceuticals Shanghai". https://titelia.com/en/stocks/immuneonco-biopharmaceuticals-shanghai-CNE100006624